RecruitingNot Applicable

A Registry Study on HIV-related Lymphoma

Germany, Netherlands, Spain300 participantsStarted 2021-08-25

Plain-language summary

Retrospective und prospective registry on HIV-associated lymphoma. Data on characteristics, type and toxicity of treatment and outcome of patients with HIV-lymphoma will be collected.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Histology or cytology proven non-Hodgkin lymphoma or Hodgkin lymphoma * HIV-infection at time of lymphoma diagnosis * Lymphoma diagnosis since 01.01.2010 * Adult patients ≥ 18 years * Written informed consent Exclusion Criteria: * HIV-diagnosis \> 3 months after the diagnosis of malignant lymphoma * Non-Compliance or lack of opportunity for follow-up (for the prospective part of the study)

What they're measuring

2-year overall survival (OS)

Timeframe: 2 years

2-year progression-free survival (PFS)

Timeframe: 2 years

Trial details

NCT IDNCT05231135

SponsorRotkreuzklinikum München gGmbH

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-08-31

Contact for this trial

Marcus Hentrich, MD

+49 89 1303 4372 marcus.hentrich@swmbrk.de

View on ClinicalTrials.gov More AIDS Related Lymphoma trials